Real World Treatment Practices for Chronic Lymphocytic Leukemia in Japan: An Observational Database Research Study (CLIMBER-DBR)-Reference-Cited by-同舟云学术

Real World Treatment Practices for Chronic Lymphocytic Leukemia in Japan: An Observational Database Research Study (CLIMBER-DBR)

Published:2021 Issue:3 Volume:61 Page:126-134
ISSN:1346-4280
Container-title:Journal of Clinical and Experimental Hematopathology
language:en
Short-container-title:J Clin Exp Hematopathol

Author:

Takizawa Jun¹,Izutsu Koji²,Nagai Hirokazu³,Fukase Kenjiro⁴,Nakamura Maki⁴,Jinushi Masahisa⁴,Suzumiya Junji⁵

Affiliation:

1. Department of Hematology, Endocrinology and Metabolism, Niigata University Faculty of Medicine, Niigata, Japan,

2. Department of Hematology, National Cancer Center Hospital, Tokyo, Japan,

3. Department of Hematology, National Hospital Organization Nagoya Medical Center, Nagoya, Japan,

4. AstraZeneca K.K., Osaka, Japan,

5. Innovative Cancer Center, Shimane University Hospital, Izumo, Japan

Publisher

Japanese Society for Lymphoreticular Tissue Research

Subject

General Medicine

Link

https://www.jstage.jst.go.jp/article/jslrt/61/3/61_20044/_pdf

Reference21 articles.

1. 1 Chihara D, Ito H, Matsuda T et al. Differences in incidence and trends of haematological malignancies in Japan and the United States. Br J Haematol. 2014; 164: 536-545.

2. 2 Ministry of Health LaW. Patient survey 2017. Available at: https://www.e-stat.go.jp/stat-search/files?page=1&layout=datalist&toukei=00450022&tstat=000001031167&cycle=7&tclass1=000001124800&tclass2=000001124803&stat_infid=000031790842. Accessed June 16, 2020 [in Japanese].

3. 3 . The World Health Organization classification of malignant lymphomas in Japan: incidence of recently recognized entities. Pathol Int. 2000; 50: 696-702.

4. 4 Rai KR, Jain P. Chronic lymphocytic leukemia (CLL)-Then and now. Am J Hematol. 2016; 91: 330-340.

5. 5 Suzumiya J, Takizawa J. Evolution in the management of chronic lymphocytic leukemia in Japan: should MRD negativity be the goal? Int J Hematol. 2020; 111: 642-656.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Improving the external validity of randomized clinical trials: The interesting place of weighting survey methods;2024-04-29

2. Real-world outcomes of venetoclax and rituximab for chronic lymphocytic leukemia/small lymphocytic lymphoma: A retrospective analysis of nine Japanese cases;Journal of Clinical and Experimental Hematopathology;2024

3. Treatment patterns in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma post covalent Bruton tyrosine kinase inhibitor treatment: a Japanese claims database study;Journal of Clinical and Experimental Hematopathology;2023-12-26